TD Waterhouse Canada Inc. Purchases 29,752 Shares of GE HealthCare Technologies Inc. $GEHC

TD Waterhouse Canada Inc. grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 608,890 shares of the company’s stock after purchasing an additional 29,752 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in GE HealthCare Technologies were worth $39,015,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Mount Vernon Associates Inc. MD raised its position in shares of GE HealthCare Technologies by 0.8% in the first quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after buying an additional 144 shares during the last quarter. Essex Financial Services Inc. lifted its stake in shares of GE HealthCare Technologies by 1.8% during the first quarter. Essex Financial Services Inc. now owns 9,024 shares of the company’s stock valued at $642,000 after buying an additional 156 shares during the period. Brown Lisle Cummings Inc. lifted its stake in shares of GE HealthCare Technologies by 29.3% during the first quarter. Brown Lisle Cummings Inc. now owns 706 shares of the company’s stock valued at $50,000 after buying an additional 160 shares during the period. Beacon Financial Advisory LLC lifted its stake in shares of GE HealthCare Technologies by 5.8% during the first quarter. Beacon Financial Advisory LLC now owns 2,965 shares of the company’s stock valued at $211,000 after buying an additional 162 shares during the period. Finally, Physician Wealth Advisors Inc. boosted its position in GE HealthCare Technologies by 60.4% during the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock worth $31,000 after acquiring an additional 163 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.1%

Shares of NASDAQ:GEHC opened at $69.57 on Friday. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. The firm has a market cap of $31.42 billion, a price-to-earnings ratio of 15.96, a PEG ratio of 1.84 and a beta of 0.73. The stock’s 50-day moving average price is $68.54 and its two-hundred day moving average price is $66.79. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the company posted $1.06 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be given a $0.04 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. GE HealthCare Technologies’s dividend payout ratio is 3.21%.

Analyst Ratings Changes

A number of brokerages recently issued reports on GEHC. Weiss Ratings upgraded shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Evercore reiterated an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Oppenheimer reiterated an “outperform” rating on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Zacks Research raised GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, BTIG Research reduced their price target on GE HealthCare Technologies from $79.00 to $75.00 and set a “buy” rating on the stock in a research note on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $78.35.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc is a global medical technology and healthcare services company that develops, manufactures and supports products used by hospitals, clinicians and researchers. Its offerings are designed to assist with disease detection, diagnosis, treatment, patient monitoring and clinical workflow management.

The company’s portfolio includes computed tomography, magnetic resonance imaging, X-ray and molecular imaging systems; ultrasound equipment; patient monitoring and anesthesia delivery technologies; and pharmaceutical diagnostics, including contrast agents used in medical imaging.